These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2954110)

  • 1. [An unrecognized cause of allergic eczema of the face: a corticoid, tixocortol pivalate].
    Foussereau J; Jelen G
    Presse Med; 1987 May; 16(17):832. PubMed ID: 2954110
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone.
    Lauerma AI
    Contact Dermatitis; 1991 Feb; 24(2):123-30. PubMed ID: 1828209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short induction phase of contact allergy to tixocortol pivalate in a nasal spray.
    Bircher AJ
    Contact Dermatitis; 1990 Apr; 22(4):237-8. PubMed ID: 2140756
    [No Abstract]   [Full Text] [Related]  

  • 4. The significance of tixocortol-pivalate-positive patch tests in leg ulcer patients.
    Wilkinson M; Cartwright P; English JS
    Contact Dermatitis; 1990 Aug; 23(2):120-1. PubMed ID: 2145125
    [No Abstract]   [Full Text] [Related]  

  • 5. Contact stomatitis from tixocortol pivalate.
    Callens A; Vaillant L; Machet L; Pelucio-Lopez C; de Calan S; Lorette G
    Contact Dermatitis; 1993 Sep; 29(3):161. PubMed ID: 8222636
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydrocortisone sensitivity. An investigation into the nature of the allergen.
    Wilkinson SM; English JS
    Contact Dermatitis; 1991 Sep; 25(3):178-81. PubMed ID: 1838313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid contact hypersensitivity: what vehicle and concentration?
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1996 May; 34(5):305-8. PubMed ID: 8807220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity of tixocortol pivalate-positive patients in intradermal and oral provocation tests.
    Räsänen L; Tuomi ML; Ylitalo L
    Br J Dermatol; 1996 Dec; 135(6):931-4. PubMed ID: 8977714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contact hypersensitivity to tixocortol pivalate.
    Lutz ME; el-Azhary RA; Gibson LE; Fransway AF
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):691-5. PubMed ID: 9591812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guinea pig maximization test assessment of hydrocortisone and tixocortol pivalate.
    Mirshahpanah P; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(4):375-82. PubMed ID: 18058310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic contact dermatitis induced by topical hydrocortisone butyrate propionate mimicking acute generalized exanthematous pustulosis.
    TOHGI N; ETO H; MAEJIMA H; SAITO N; NAKAMURA M; KATSUOKA K
    Eur J Dermatol; 2009; 19(5):518-9. PubMed ID: 19527994
    [No Abstract]   [Full Text] [Related]  

  • 12. Probable active sensitization to tixocortol pivalate.
    Goldsmith PC; White IR; Rycroft RJ; McFadden JP
    Contact Dermatitis; 1995 Dec; 33(6):429. PubMed ID: 8706404
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contact allergy to topical glucocorticoids].
    Dooms-Goossens A
    Hautarzt; 1994 Mar; 45(3):196. PubMed ID: 8175354
    [No Abstract]   [Full Text] [Related]  

  • 14. Allergic reactions to topical corticosteroids or their vehicles.
    Fisher AA
    Cutis; 1983 Aug; 32(2):122, 129-32, 137. PubMed ID: 6225625
    [No Abstract]   [Full Text] [Related]  

  • 15. Contact hypersensitivity to hydrocortisone-free-alcohol in patients with allergic patch test reactions to tixocortol pivalate.
    Lauerma AI; Tarvainen K; Forström L; Reitamo S
    Contact Dermatitis; 1993 Jan; 28(1):10-4. PubMed ID: 8428438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patch-testing with serial dilutions of tixocortol pivalate and potential cross-reactive substances.
    Isaksson M; Bruze M; Goossens A; Lepoittevin JP
    Acta Derm Venereol; 2000; 80(1):33-8. PubMed ID: 10721831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patch testing for corticosteroid allergy with low and high concentrations of tixocortol pivalate and budesonide.
    Chowdhury MM; Statham BN; Sansom JE; Foulds IS; English JS; Podmore P; Bourke J; Orton D; Ormerod AD
    Contact Dermatitis; 2002 May; 46(5):311-2. PubMed ID: 12084094
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations.
    Shaw DW; Maibach HI
    Contact Dermatitis; 2013 Jun; 68(6):369-75. PubMed ID: 23692037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patch test results with tixocortol pivalate and budesonide in Germany and Austria.
    Uter W; Geier J; Richter G; Schnuch A;
    Contact Dermatitis; 2001 May; 44(5):313-4. PubMed ID: 11380156
    [No Abstract]   [Full Text] [Related]  

  • 20. A survey of the results of patch tests with tixocortol pivalate.
    Dooms-Goossens A; Andersen KE; Burrows D; Camarasa JG; Ducombs G; Frosch PJ; Lachapelle JM; Lahti A; Menné T; Rycroft RJ
    Contact Dermatitis; 1989 Feb; 20(2):158. PubMed ID: 2706969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.